Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: Noopept evidence and protocol review
Also known as: GVS-111, Omberacetam
Noopept is a synthetic dipeptide developed in Russia, described as racetam-adjacent and typically dosed at 10-30 mg - roughly a thousandfold lower than piracetam's gram-scale dosing. A comparative trial (Neznamov & Teleshova, 2009; 53 patients with mild cognitive disorders of vascular or traumatic origin) found Noopept (20mg/day) produced more pronounced cognitive effects than piracetam (1200mg/day) over 56 days. Proposed mechanisms include modulation of cholinergic and glutamatergic signaling and increased NGF/BDNF expression, with antioxidant/neuroprotective effects reported in animal models. Noopept is metabolized to cycloprolylglycine (CPG), itself a GABA-B receptor modulator. By contrast, a 2024 meta-analysis of piracetam (18 studies, 886 patients) found no clinically meaningful memory-enhancement difference versus control, indicating limited efficacy for the broader racetam class in adults.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Noopept is not FDA-approved. Independent replication and modern safety data are limited.
Supplementary research context only. Not medical advice or a treatment recommendation.
Best-effort summary of forum/Reddit discussion. This is anecdotal community commentary, not a scientific source, and does not count toward this record's verification status. Do not treat it as established fact or medical guidance.
Community discussion of Noopept is extensive and mixed: some users report noticeable cognitive benefits, others report being non-responders or question whether it is worth taking; discussion also touches on safety questions. Anecdotal, not clinically verified to the standard of controlled human trials.
Community discussion weighing whether Noopept's effects justify continued use; mixed responses from experienced users.
Community discussion debating Noopept's standing among nootropics, with varied personal experiences shared.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention Noopept or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.